本页面由Tiger Trade Technology Pte. Ltd.提供服务

Recursion Pharmaceuticals, Inc.

4.03
-0.3350-7.68%
成交量:1,132.48万
成交额:4,671.89万
市值:21.53亿
市盈率:-3.94
高:4.37
开:4.31
低:4.02
收:4.36
52周最高:7.18
52周最低:2.77
股本:5.35亿
流通股本:5.22亿
量比:0.80
换手率:2.17%
股息:- -
股息率:- -
每股收益(TTM):-1.0219
每股收益(LYR):-1.4410
净资产收益率:-56.58%
总资产收益率:-27.33%
市净率:2.35
市盈率(LYR):-2.79

数据加载中...

2026/07/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/30

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/18

重要事件披露

Form 8-K - Current report